Metronidazole Preferred Pharmaceuticals Inc. (MPPI) is a company that supplies metronidazole, an antibiotic used to treat a variety of bacterial and parasitic infections [1]. The drug is available in various forms, including tablets, capsules, and intravenous solutions [1].
What infections does metronidazole treat?
Metronidazole is effective against anaerobic bacteria and certain parasites [1]. It is commonly prescribed for conditions such as bacterial vaginosis, trichomoniasis, amebiasis, and giardiasis [1]. It is also used to treat infections of the skin, respiratory tract, and gastrointestinal tract [1].
How does metronidazole work?
Metronidazole is a nitroimidazole antibiotic [1]. Its mechanism of action involves entering the microbial cell, where its nitro group is reduced to form toxic free radicals. These radicals disrupt bacterial DNA synthesis and cause cell death [1].
What are the common side effects of metronidazole?
Common side effects associated with metronidazole use include nausea, vomiting, diarrhea, abdominal pain, and a metallic taste in the mouth [1]. Less common side effects can include dizziness, headaches, and rash [1]. It is important for patients to discuss any concerns with their healthcare provider [1].
When does the patent for metronidazole expire?
Metronidazole is an older drug, and its original patents have long expired [2]. This means that generic versions of metronidazole are widely available. Companies like Metronidazole Preferred Pharmaceuticals Inc. likely operate in the generic pharmaceutical market [1, 2].
Who makes generic metronidazole?
Numerous pharmaceutical companies manufacture generic metronidazole [2]. Metronidazole Preferred Pharmaceuticals Inc. is one such supplier [1]. The availability of generic options makes the medication more accessible and affordable [2].
Are there alternatives to metronidazole?
Depending on the specific infection, alternative antibiotics or antiparasitic drugs may be available [3]. For example, treatment for bacterial vaginosis might involve clindamycin, while trichomoniasis can also be treated with other agents [3]. The choice of treatment is based on the type of infection, patient factors, and drug resistance patterns [3].